5-nitro-2-furoic acid has been researched along with Chagas Disease in 1 studies
*Chagas Disease: Infection with the protozoan parasite TRYPANOSOMA CRUZI, a form of TRYPANOSOMIASIS endemic in Central and South America. It is named after the Brazilian physician Carlos Chagas, who discovered the parasite. Infection by the parasite (positive serologic result only) is distinguished from the clinical manifestations that develop years later, such as destruction of PARASYMPATHETIC GANGLIA; CHAGAS CARDIOMYOPATHY; and dysfunction of the ESOPHAGUS or COLON. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arias, DG; Bürgi, MD; Cravero, RM; Forastieri, PS; Garay, AS; Guerrero, SA; Herrera, FE; Iglesias, AA; Luna, LE; Prieto, C; Rodrigues, D | 1 |
1 other study(ies) available for 5-nitro-2-furoic acid and Chagas Disease
| Article | Year |
|---|---|
Rational design of nitrofuran derivatives: Synthesis and valuation as inhibitors of Trypanosoma cruzi trypanothione reductase.
Topics: Chagas Disease; Drug Design; Enzyme Inhibitors; HeLa Cells; Humans; Molecular Docking Simulation; NADH, NADPH Oxidoreductases; Nitrofurans; Trypanocidal Agents; Trypanosoma cruzi | 2017 |